Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 81 of the 84 references it cites were found in a registry or an index; 12 of the 23 sources its claims cite were checked for support.

Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study

Open access
Hartong, Vincent, van Emmerik, Arnold · 2023 · Journal of Psychoactive Drugs

Abstract

While anecdotal reports claim that psychedelic microdosing reduces anxiety and mood symptoms, evidence supporting these claims is scarce. This cross-sectional study investigated the association between microdosing and trait anxiety. Furthermore, it was investigated if trait mindfulness mediated this association. Participants completed anonymous online questionnaires and were divided into three groups: current microdosers (n = 186), former microdosers (n = 77) and microdosing-naïve controls (n = 234). Trait anxiety and trait mindfulness were measured using the State-Trait Anxiety Inventory–Trait subscale (STAI-T) and the 15-item Five-Facet Mindfulness Questionnaire (FFMQ-15) respectively. Current and former microdosers reported lower STAI-T scores compared to microdosing-naïve controls. Furthermore, associations of current and former microdosing with trait anxiety were mediated by trait mindfulness, with small effects of FFMQ-15 Total, Non-judging and Non-reactivity scores. However, in an exploratory analysis, all associations between microdosing and STAI-T scores became non-significant when participants with previous macrodose experience (n = 386) were excluded. Our findings suggest that RCT<apos;>s are warranted to test causal hypotheses concerning the effects of microdosing and the role of trait mindfulness in the effects of microdosing, while controlling for previous macrodose experience. © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

Overview

CoChat Summary

TL;DR

In a cross-sectional online survey of 497 participants, current and former psychedelic microdosers reported lower trait anxiety than microdosing-naïve controls, and trait mindfulness mediated these associations. However, associations became non-significant when participants with previous macrodose experience were excluded, suggesting macrodose history may explain the findings.

Key findings

  • Current microdosers vs microdosing-naïve controls reported lower STAI-T scores (B = -5.26, SE = 1.16, p < .001; r = .22, adjusted r² = .05, F[1,418] = 20.74).
  • Former microdosers vs controls also reported lower STAI-T scores (B = -4.33, SE = 1.58, p = .007; r = .15, adjusted r² = .02, F[1,309] = 7.49).
  • The current-microdosing association was mediated by FFMQ-15 total and all subscale scores; the former-microdosing association was mediated by FFMQ-15 total, observing, non-judging, and non-reactivity scores, with significant indirect effects using 5,000 bootstrapped samples and 95% CIs not containing zero.
  • In exploratory analysis excluding participants with previous macrodose experience (n = 386), the microdosing–STAI-T association became non-significant (r = .05, adjusted r² < .01, F[1,202] = .57); previous macrodose experience was associated with lower STAI-T scores (B = -3.76, SE = 1.09, p = .001), mediated by FFMQ-15 total (standardized indirect effect = .14).

Methods

  • Cross-sectional anonymous online questionnaires recruited in October–November 2020 via Reddit (n = 641) and a university research advertising website (n = 100); after exclusions, 497 participants were analyzed: current microdosers (n = 186), former microdosers (n = 77), and microdosing-naïve controls (n = 234).
  • Trait anxiety was measured with the STAI-T; trait mindfulness with the FFMQ-15; participants also reported demographics, microdosing experience, previous macrodose experience, and current mindfulness practice.
  • Analysis used ANOVA and chi-squared tests for group differences, linear regression for microdosing–STAI-T associations, and mediation via joint significance tests plus percentile bootstrapping (PROCESS, 5,000 samples); exploratory analyses excluded participants with previous macrodose experience.

Limitations

  • Stated: cross-sectional design cannot infer causality; microdosing was broadly operationalized, with duration, frequency, exact doses, and time since quitting unknown, producing a heterogeneous sample; STAI-T construct validity has been criticized and may measure general negative affect; demographic between-group differences (age, gender, education; controls mostly female first-year bachelor students) may have influenced associations.
  • Stated: the exploratory analysis excluding macrodose-experienced participants did not meet power requirements; placebo/expectancy effects are an alternative explanation for the findings.
  • Evident from the design: self-report online data with no placebo control limit causal and generalizability claims.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/02791072.2022.2080616

Cites

81 of 84 references verified1 citation errors · 2 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

7 Valid · 6 Not valid · 5 Not checked · 45 Own results and interpretations

31 more claims

Create a free account to see all 63 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 5
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 79 references

Research works printed but not linked: 4

  1. 10.1016/S2215-0366/2816/2930065-7 · doi:10.1016/s2215-0366/2816/2930065-7
  2. Fadiman J., 2011, The psychedelic explorer’s guide
  3. Kabat-Zinn J., 1990, Full catastrophe living: The program of the stress reduction clinic at the University of Massachusetts Medical Center
  4. Waldman A., 2017, A really good day: How microdosing made a mega difference in my mood, my marriage, and my life

Cited by

See all 12

Metadata

Authors
Hartong, V., & van Emmerik, A.
Affiliations
  • University of Amsterdam (NL)
  • Department of Psychology, Faculty of Social and Behavioural Sciences, University of Amsterdam, Amsterdam, Netherlands
Venue
Journal of Psychoactive Drugs
Published
2022-06-12
Volume
55
Issue
3
Pages
310-320
ISSN
  • 0279-1072 (ISSN-L)
  • 2159-9777
OpenAlex
W4281724869
Cited by
11
References
79
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3
FWCI
2.28
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychoactive Drugs (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion, cc-by-nc-nd)
Funders
The author(s) reported there is no funding associated with the work featured in this article
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Psychology › Social Psychology › Psychological Well-being and Life Satisfaction
Keywords
psychedelic microdosing, trait anxiety, trait mindfulness, mediation, non-judgment, non-reactivity, mood symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study. https://app.cochat.ai/papers/10.1080/02791072.2022.2080616
The paper
Hartong, V., & van Emmerik, A. (2023). Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2022.2080616

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.